Our results revealed that tumor Sdc-1 silencing promotes the proportion of Th1 (IFN-γ+CD4+) subset of non-IBC patients when stimulated with the secretome of Sdc-1-silenced SUM-149 cells but not in direct co-culture, as compared to negative control. Here, SDC1 is linked to inflammatory breast carcinoma.